Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids

被引:46
|
作者
Mena, I
Vivo, A
Perez, E
Portela, A
机构
[1] INST SALUD CARLOS III, CTR NACL BIOL CELULAR & RETROVIRUS, E-28220 MAJADAHONDA, MADRID, SPAIN
[2] INST SALUD CARLOS III, CTR NACL MICROBIOL VIROL & IMMUNOL SANIT, E-28220 MAJADAHONDA, MADRID, SPAIN
关键词
D O I
10.1128/JVI.70.8.5016-5024.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have shown previously that COS-1 cells infected with a vaccinia virus recombinant (vTF7-3) which expresses the T7 RNA polymerase gene and then transfected with four pGEM-derived plasmids encoding the influenza A virus core proteins (nucleoprotein, PBI, PB2, and PA polypeptides) can express a synthetic influenza virus-like chloramphenical acetyltransferase (CAT) RNA (I, Mena, S, de la Luna, C, Albo, J, Martin, A, Nieto, J, Ortin, and A, Portela, J, Gen, Virol, 75:2109-2114, 1994), Here we demonstrate that by supplying the vTF7-3-infected cells with plasmids containing cDNAs of all 10 influenza virus-encoded proteins, the transfected CAT RNA can be expressed and rescued into particles that are budded into the supernatant fluids. The released particles can transfer the enclosed CAT RNA to MDCK cultures and resemble true influenza virions in that they require trypsin treatment to deliver the RNA to fresh cells and are neutralized by a monoclonal antibody specific for the influenza A virus hemagglutinin. Moreover, analysis by electron microscopy showed that the culture medium harvested from the transfected cells contained vesicles that could be labeled with an anti-HA monoclonal antibody and that were similar in size and morphology to authentic influenza virus particles, It is also shown that detection of recombinant particles capable of transmitting the CAT RNA does not require expression of the influenza virus nonstructural protein NS1, All of these data indicate that influenza virus-like particles enclosing a synthetic virus-like RNA can be assembled in cells expressing all viral structural components from recombinant plasmids.
引用
收藏
页码:5016 / 5024
页数:9
相关论文
共 50 条
  • [41] Seroepidemiology of human bocavirus defined using recombinant virus-like particles
    Kahn, Jeffrey S.
    Kesebir, Deniz
    Cotmore, Susan F.
    D'Abramo, Anthony, Jr.
    Cosby, Christi
    Weibel, Carla
    Tattersall, Peter
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (01): : 41 - 50
  • [42] Production of Japanese encephalitis virus-like particles by recombinant insect cells
    Yamaji, Hideki
    Takahashi, Yusuke
    Nakamura, Masataka
    Katsuda, Tomohisa
    Kuwahara, Miwa
    Konishi, Eiji
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2009, 108 : S7 - S7
  • [43] Immune response modulation by recombinant peptides expressed in virus-like particles
    Svirshchevskaya, EV
    Alekseeva, L
    Marchenko, A
    Viskova, N
    Andronova, TM
    Benevolenskii, SV
    Kurup, VP
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (02): : 199 - 205
  • [44] SOME PROPERTIES OF RNA FROM VIRUS-LIKE PARTICLES IN PYRICULARIA-ORYZAE CAVARA
    IKEGAMI, M
    HIRAI, T
    MICROBIOLOGY AND IMMUNOLOGY, 1978, 22 (09) : 569 - 574
  • [45] Rescue of synthetic RNAs into Thogoto and influenza A virus particles using core proteins purified from Thogoto virus
    Gómez-Puertas, P
    Leahy, MB
    Nuttall, PA
    Portela, A
    VIRUS RESEARCH, 2000, 67 (01) : 41 - 48
  • [46] Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer
    Li, Jinming
    Sun, Yanli
    Jia, Tingting
    Zhang, Rui
    Zhang, Kuo
    Wang, Lunan
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (07) : 1683 - 1694
  • [47] RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform
    Hwang, Beom Jeung
    Jang, Yohan
    Kwon, Soon Bin
    Yu, Ji Eun
    Lim, Jongkwan
    Roh, Young Hoon
    Seong, Baik L.
    BIOMATERIALS, 2021, 269
  • [48] Multifaceted virus-like particles: Navigating towards broadly effective influenza A virus vaccines
    Norizwan, Jaffar Ali Muhamad
    Tan, Wen Siang
    CURRENT RESEARCH IN MICROBIAL SCIENCES, 2025, 8
  • [49] Receptor-mediated gene delivery with synthetic virus-like particles
    Wagner, E
    Cotten, M
    Zatloukal, K
    TARGETING OF DRUGS 5: STRATEGIES FOR OLIGONUCLEOTIDE AND GENE DELIVERY IN THERAPY, 1996, 290 : 67 - 77
  • [50] Synthetic Virus-Like Particles and Conformationally Constrained Peptidomimetics in Vaccine Design
    Riedel, Tina
    Ghasparian, Arin
    Moehle, Kerstin
    Rusert, Peter
    Trkola, Alexandra
    Robinson, John A.
    CHEMBIOCHEM, 2011, 12 (18) : 2829 - 2836